Cosmetic cross-reference

Cetrimonium Bromide

CAS 57-09-0

Cetrimonium Bromide (CAS 57-09-0) is a Phase 2 pharmaceutical compound with 1 bioactivity target and 1,499 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

1,499

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Cetrimonium Bromide

CAS Number

57-09-0

UNII

L64N7M9BWR

InChIKey

LZZYPRNAOMGNLH-UHFFFAOYSA-M

ChEMBL ID

CHEMBL307346

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL307346 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	IC50	19976.309999999998 nM	1	-
Dynamin-1 Structural	IC50	5.36	-	Homo sapiens

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
Cetrimonium Bromide	288999	SU	MTHSPL
cetrimonium bromide	288999	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Cetrimonium Bromide used for in pharmaceutical contexts?

Cetrimonium Bromide (CAS 57-09-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Cetrimonium Bromide?

Cetrimonium Bromide has 1,499 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Accidental overdose. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Cetrimonium Bromide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Cetrimonium Bromide with EU status "restricted".

What clinical phase is Cetrimonium Bromide in?

Cetrimonium Bromide is rendered with ChEMBL max phase 2.

What bioactivity targets are documented for Cetrimonium Bromide?

Cetrimonium Bromide has 2 bioactivity rows in this page query. Rendered target entries include Dynamin-1.